LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

LLY

1,023.96

+0.31%↑

JNJ

196.01

+0.34%↑

ABBV

232.37

0%↓

UNH

321.37

-3.25%↓

AZN

89.14

+0.64%↑

Home・Stock List・Pulse Biosciences Inc

Pulse Biosciences Inc

Closed

SectorHealthcare

14.31 2

Buy Sell

Overview

Share price change

24h

Current

Min

13.98

Max

14.6

Key metrics
By Trading Economics
Income	-217K -19M
Sales	86K 86K
EPS	-0.29
Profit margin	-22,540.698
Employees	75
EBITDA	-1.2M -20M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+46.67% upside

Market Stats
By TradingEconomics
Market Cap	-97M 1B
Previous open	12.31
Previous close	14.31

News Sentiment

By Acuity

67%

33%

328 / 374 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

16.59 / 17.17 Support & Resistance

Pulse Biosciences Inc Chart

Past performance is not a reliable indicator of future results.

Related News

13 Nov 2025, 21:34 UTC

Earnings

Applied Materials 4Q Sales Fall; Forecasts Higher Demand in 2H26

13 Nov 2025, 23:45 UTC

Market Talk

Nikkei May Fall After Wall Street's Weakness -- Market Talk

13 Nov 2025, 23:42 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 4th Update

13 Nov 2025, 23:41 UTC

Market Talk

Gold Edges Higher on Possible Dip-Buying -- Market Talk

13 Nov 2025, 23:24 UTC

Earnings

JBS NV: Robust U.S. Beef Demand Supported 3Q North America Sales >JBS

13 Nov 2025, 23:24 UTC

Earnings

JBS NV: Live Cattle Prices Have Remained High, Pressuring Profitability >JBS

13 Nov 2025, 23:23 UTC

Earnings

JBS NV 3Q EPS 52c >JBS

13 Nov 2025, 23:23 UTC

Earnings

JBS NV 3Q Sales $22.6B >JBS

13 Nov 2025, 23:04 UTC

Market Talk

RBA Looks Set To Remain Sidelined For a While Yet -- Market Talk

13 Nov 2025, 22:02 UTC

Earnings

Nu Holdings 3Q Net $783M >NU

13 Nov 2025, 22:01 UTC

Earnings

Nu Holdings 3Q Rev $4.2B >NU

13 Nov 2025, 21:51 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 3rd Update

13 Nov 2025, 21:50 UTC

Earnings

Disney Posts Roughly Flat Quarterly Revenue as TV Declines Continue -- 4th Update

13 Nov 2025, 21:45 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- 2nd Update

13 Nov 2025, 21:41 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- Update

13 Nov 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Paramount Plans to Bid for All of Warner Bros., Sources Say -- WSJ

13 Nov 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Among Potential Bidders That Have Looked at Warner Bros. Financials, Sources Say -- WSJ

13 Nov 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Paramount, Comcast, Netflix Prepare Bids for Warner As Deadline Approaches -- WSJ

13 Nov 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Netflix, Comcast Each Considering Pursuing Warner Bros. Studio, Streaming Assets, Sources Say -- WSJ

13 Nov 2025, 21:36 UTC

Acquisitions, Mergers, Takeovers

Bids for Warner Bros. Discovery Due Next Week, Sources Say -- WSJ

13 Nov 2025, 21:33 UTC

Market Talk

Banks See CAD Appreciation Through 2026, Trade Poses 'Clear' Risk -- Market Talk

13 Nov 2025, 21:33 UTC

Earnings

If Investors Like Rocket Lab Stock, They Should Love Firefly Shares -- Barrons.com

13 Nov 2025, 21:31 UTC

Earnings

Applied Materials Stock Falls Despite Strong Earnings -- Barrons.com

13 Nov 2025, 21:25 UTC

Earnings

Figure Tech Solutions 3Q Rev $156.4M >FIGR

13 Nov 2025, 21:25 UTC

Earnings

Figure Tech Solutions 3Q EPS 34c >FIGR

13 Nov 2025, 21:23 UTC

Earnings

Intchains Group 3Q Rev $1.3M >ICG

13 Nov 2025, 21:03 UTC

Earnings

Applied Materials Sees 1Q Rev $6.35B-$7.35B >AMAT

13 Nov 2025, 21:02 UTC

Earnings

Applied Materials Sees 1Q Adj EPS $1.98-Adj EPS $2.38 >AMAT

13 Nov 2025, 21:01 UTC

Earnings

Applied Materials 4Q Rev $6.8B >AMAT

13 Nov 2025, 21:01 UTC

Earnings

Applied Materials 4Q Gross Margin 48.0% >AMAT

Peer Comparison

Price change

Pulse Biosciences Inc Forecast

Price Target

By TipRanks

46.67% upside

12 Months Forecast

Average 22 USD 46.67%

High 22 USD

Low 22 USD

Based on 1 Wall Street analysts offering 12 month price targets forPulse Biosciences Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

1 ratings

Buy

Hold

Sell

Based on 1 analysts giving stock ratings to Pulse Biosciences Inc - Dist in the past 3 months.

Technical Score

By Trading Central

16.59 / 17.17Support & Resistance

Recent bearish events outweigh bullish events.

Sentiment

By Acuity

328 / 374 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.